Resources

In this week's Homerun Slides, testing albuminuria and potassium levels.

Type 2 diabetes mellitus (T2DM) is not simply a disorder of blood sugar control, but a condition in which multiple biochemical pathways are impacted. An illustrative example of this is the elevated blood ketone body concentration typical of T2DM, which can progress to diabetic ketoacidosis if insulin action and/or availability deteriorates.The elevations of ketone bodies and the acetone accumulation (with associated “sweet breath odor”) of severe or poorly controlled diabetes are indicative of abnormal fatty acid homeostasis and specifically, high lipolysis and hepatic beta-oxidation.

Second-line treatment is often initiated without evidence of recommended use of first-line treatment.

Recent meta-analysis conducted to address ideal amount of dietary carbohydrates in the management of T2DM.

Trial shows HbA1c reduced, hypoglycemia and DKA similar across study participants.

Increased risk for cardiac events, hospitalization clear predictors of death.

By Guest Writer David Kliff, Diabetic Investor: As we were getting ready to disembark the plane when it arrived in Lisbon I asked a long-term consultant to the diabetes industry why he comes to EASD. “I like to come here because what they have here will show up in our country in two years” was his response. Given what we witnessed at EASD there isn’t much to look forward to in 2019.

A 41-year-old patient with a BMI of 39 kg/m2 returns for a follow-up visit 3 months after initiating metformin. She is highly sensitive to her weight and has tried to implement lifestyle modifications, but is finding it difficult to make any meaningful changes in her diet or exercise routines. Her current A1C is 7.7%, with a target goal A1C<7%. In addition to discussing consideration of bariatric surgery, which drug class might you add? A. Thiazolidinedione B. Sulfonylurea C. DDP-4 inhibitor D. GLP-1 receptor agonist Follow the link to see the correct answer.

Jane Dickinson and Susan Guzman discuss the language of diabetes: why the way we talk to and about patients, and the way we listen to them, matters so much for effective disease management.

Jane Dickinson and Susan Guzman discuss the language of diabetes, and why the specific terms we use when discussing patients with diabetes, their behavior, and their problems, are so important.